Anti-SERPINB13 monoclonal antibody

Pre-made anti-SERPINB13 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SERPINB13/SERPINB13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1616-Ab-1/ GM-Tg-hg-IP1616-Ab-2Anti-Human SERPINB13 monoclonal antibodyHuman
GM-Tg-rg-IP1616-Ab-1/ GM-Tg-rg-IP1616-Ab-2Anti-Rat SERPINB13 monoclonal antibodyRat
GM-Tg-mg-IP1616-Ab-1/ GM-Tg-mg-IP1616-Ab-2Anti-Mouse SERPINB13 monoclonal antibodyMouse
GM-Tg-cynog-IP1616-Ab-1/ GM-Tg-cynog-IP1616-Ab-2Anti-Cynomolgus/ Rhesus macaque SERPINB13 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1616-Ab-1/ GM-Tg-felg-IP1616-Ab-2Anti-Feline SERPINB13 monoclonal antibodyFeline
GM-Tg-cang-IP1616-Ab-1/ GM-Tg-cang-IP1616-Ab-2Anti-Canine SERPINB13 monoclonal antibodyCanine
GM-Tg-bovg-IP1616-Ab-1/ GM-Tg-bovg-IP1616-Ab-2Anti-Bovine SERPINB13 monoclonal antibodyBovine
GM-Tg-equg-IP1616-Ab-1/ GM-Tg-equg-IP1616-Ab-2Anti-Equine SERPINB13 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1616-Ab-1/ GM-Tg-hg-IP1616-Ab-2; GM-Tg-rg-IP1616-Ab-1/ GM-Tg-rg-IP1616-Ab-2;
GM-Tg-mg-IP1616-Ab-1/ GM-Tg-mg-IP1616-Ab-2; GM-Tg-cynog-IP1616-Ab-1/ GM-Tg-cynog-IP1616-Ab-2;
GM-Tg-felg-IP1616-Ab-1/ GM-Tg-felg-IP1616-Ab-2; GM-Tg-cang-IP1616-Ab-1/ GM-Tg-cang-IP1616-Ab-2;
GM-Tg-bovg-IP1616-Ab-1/ GM-Tg-bovg-IP1616-Ab-2; GM-Tg-equg-IP1616-Ab-1/ GM-Tg-equg-IP1616-Ab-2
Products NameAnti-SERPINB13 monoclonal antibody
Formatmab
Target NameSERPINB13
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SERPINB13 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1616-Ag-1Recombinant multi-species SPB13/ SERPINB13/ HSHUR7SEQ protein
    ORF Viral VectorpGMLP003637human SERPINB13 Lentivirus plasmid
    ORF Viral VectorvGMLP003637human SERPINB13 Lentivirus particle


    Target information

    Target IDGM-IP1616
    Target NameSERPINB13
    Gene ID5275,241196,304690,701078,483955,101084064,100051229
    Gene Symbol and Synonyms5430417G24,headpin,HSHUR7SEQ,HUR7,HURPIN,PI13,SERPINB13
    Uniprot AccessionQ9UIV8
    Uniprot Entry NameSPB13_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000197641
    Target ClassificationN/A

    The target: SERPINB13, gene name: SERPINB13, also named as HSHUR7SEQ, HUR7, PI13, headpin. The protein encoded by this gene is a member of the serpin family of serine protease inhibitors. The encoded protein inhibits the activity of cathepsin K and is itself transcriptionally repressed by RUNX1. This gene is downregulated in many types of cancer. [provided by RefSeq, Jan 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.